ACTIVE SUBSTANCE / INN

PREPANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED)

Brand name(s): Prepandrix, Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals
EMA LISTED
WITHDRAWN
Influenza, Human;Immunization;Disease Outbreaks
ACTIVE SUBSTANCE
Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted)
REGULATORS
EMA
SPONSORS / MAH
GlaxoSmithKline Biologicals S.A.
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
PrepandrixGlaxoSmithKline Biologicals S.A.Withdrawn14/05/2008Influenza, Human;Immunization;Disease Outbreaks
Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline BiologicalsGlaxoSmithKline Biologicals S.A.Withdrawn26/09/2008Influenza, Human;Immunization;Disease Outbreaks

FULL INTELLIGENCE ON PREPANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →